Sale!

UCP2 Gene Hyperinsulinism Genetic Test

Original price was: $700.Current price is: $500.

-29%

The UCP2 Gene Hyperinsulinism NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the UCP2 gene associated with congenital hyperinsulinism. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variants that cause persistent hypoglycemia in infants and children. The test is essential for patients experiencing unexplained low blood sugar, seizures, or developmental delays. By identifying the specific genetic cause, healthcare providers can develop targeted treatment strategies and provide accurate genetic counseling for family planning. The test costs $500 USD and delivers results within 3-4 weeks, offering crucial insights for managing this rare metabolic disorder effectively.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

UCP2 Gene Hyperinsulinism NGS Genetic DNA Test

Comprehensive Genetic Testing for Metabolic Disorders

The UCP2 Gene Hyperinsulinism NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for rare metabolic conditions. This advanced testing methodology provides crucial insights into congenital hyperinsulinism, a serious condition characterized by excessive insulin production leading to dangerously low blood sugar levels. Understanding the genetic basis of this disorder is essential for developing effective treatment strategies and providing accurate genetic counseling for affected families.

What Does This Test Measure?

This sophisticated genetic analysis specifically targets the UCP2 (Uncoupling Protein 2) gene, which plays a critical role in regulating insulin secretion from pancreatic beta cells. The test utilizes Next-Generation Sequencing technology to:

  • Identify pathogenic variants and mutations in the UCP2 gene
  • Detect single nucleotide polymorphisms associated with hyperinsulinism
  • Analyze gene expression patterns related to insulin regulation
  • Provide comprehensive genetic profiling for metabolic disorders

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with specific clinical symptoms or family history patterns:

  • Infants and children with persistent hypoglycemia (low blood sugar)
  • Patients experiencing unexplained seizures or neurological symptoms
  • Individuals with developmental delays potentially linked to metabolic disorders
  • Those with a family history of congenital hyperinsulinism
  • Patients requiring differential diagnosis for metabolic conditions
  • Families seeking genetic counseling for future pregnancy planning

Key Benefits of Genetic Testing

Undergoing the UCP2 Gene Hyperinsulinism test provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Precise identification of the genetic cause enables targeted treatment approaches
  • Personalized Treatment: Results guide medication selection and dietary management strategies
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates timely management to prevent complications from persistent hypoglycemia
  • Comprehensive Care: Supports multidisciplinary approach involving endocrinologists and genetic specialists

Understanding Your Test Results

Our comprehensive genetic report provides detailed analysis and interpretation:

  • Positive Result: Indicates the presence of UCP2 gene mutations associated with hyperinsulinism, requiring specialized medical management
  • Negative Result: Suggests that UCP2-related hyperinsulinism is unlikely, prompting investigation of other genetic causes
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation and family studies
  • Carrier Status: Provides information about inheritance patterns and recurrence risks

Test Information and Pricing

Test Parameter Details
Test Name UCP2 Gene Hyperinsulinism NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history documentation for the patient
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications with healthcare provider
  • Understanding of potential results and their clinical significance

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures easy access to this specialized genetic testing.

Take the Next Step Toward Better Health

Don’t let uncertainty about metabolic disorders affect your quality of life. Our UCP2 Gene Hyperinsulinism NGS Genetic DNA Test provides the clarity needed for effective medical management. With our discounted price of $500 USD and comprehensive genetic analysis, you can make informed decisions about your health care journey.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment. Our genetic counselors are available to answer your questions and guide you through the testing process.

Take control of your metabolic health with advanced genetic diagnostics from General Genetics Corporation – your trusted partner in precision medicine and genetic testing excellence.